/
AMRS
$0.05-$0.01 (-21.87%)prev close
Change$-13.54
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals - Specialty
P/S (TTM)
0.1
Amyris, Inc.
Amyris, Inc. is a synthetic biotechnology enterprise with global operations in the clean health, beauty, and flavors and fragrance sectors, covering Europe, North America, Asia, and South America. The company produces and sells a variety of consumer goods, including clean beauty, personal care, and health and wellness products, as well as specialized ingredients supplied to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care industries. Its product offerings are marketed under brand names such as Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN. Amyris also engages in a collaborative agreement with the Infectious Disease Research Institute for the advancement of a COVID-19 vaccine. Founded in 2003 and based in Emeryville, California, the company operated as Amyris Biotechnologies, Inc. until it adopted its current name, Amyris, Inc., in June 2010.
amyris.com- Employees
- 1,598
- IPO / List date
- Sep 28, 2010
- HQ
- US
Held by traders on TradeandTell
No one on the platform currently holds AMRS.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AMRS as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2017-06-06 | 1-for-15reverse |
| 2008-11-20 | 92-for-1 |
Recent trades on TradeandTell
No one on the platform has traded AMRS yet.